Neuropsychiatric side-effects of lidocaine: Examples from the treatment of headache and a review

Cephalalgia

Volumn 29, Issue 5, 2009, Pages 496-508

  Gil Gouveia, R ^b   Goadsby, P J ^a,b  

^a UCSF Headache Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Headache; Lidocaine; Psychiatric reaction; Toxicity

Indexed keywords

ACETYLSALICYLIC ACID; ANTIASTHMATIC AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CHLORPROMAZINE; DOMPERIDONE; GABAPENTIN; GRANISETRON; LAMOTRIGINE; LEVOTHYROXINE; LIDOCAINE; METHOTREXATE; NAPROXEN; PHENYTOIN; SPASMOLYTIC AGENT; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; ZOLPIDEM;

ADVERSE DRUG REACTION; ARTICLE; AUDITORY HALLUCINATION; BLURRED VISION; BRADYCARDIA; CLINICAL FEATURE; COGNITIVE DEFECT; COMORBIDITY; CONFUSION; CONSTIPATION; DEPRESSION; DIPLOPIA; DIZZINESS; DROWSINESS; DRUG WITHDRAWAL; DYSPHORIA; FATIGUE; HEADACHE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; HYPOTENSION; MENTAL DISEASE; NAUSEA; NEUROPSYCHIATRY; PARANOIA; PARESTHESIA; TACHYCARDIA; TREATMENT WITHDRAWAL; VISUAL DISORDER; VISUAL HALLUCINATION; VITAMIN SUPPLEMENTATION;

ADULT; AGED; ANESTHETICS, LOCAL; BRADYCARDIA; FEMALE; HEADACHE; HUMANS; HYPERTENSION; LIDOCAINE; MALE; MENTAL DISORDERS; MIDDLE AGED; NERVOUS SYSTEM DISEASES; TACHYCARDIA;

EID: 63849210330     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01800.x     Document Type: Article

References (86)

1. Collinsworth KA, Kalman SM, Harrison DC. The clinical pharmacology of lidocaine as an antiarrhythymic drug. Circulation 1974 50 : 1217 30.
2. Mao J, Chen LL. Systemic lidocaine for neuropathic pain relief. Pain 2000 87 : 7 17.
3. Rosner S. A simple method of treatment for the acute headache. Headache 1984 24 : 50.
4. + channels by local anesthetics. Science 1994 265 : 1724 8.
5. Kaube H, Hoskin KL, Goadsby PJ. Lignocaine and headache: an electrophysiological study in the cat with supporting clinical observations in man. J Neurol 1994 241 : 415 20.
6. Goldman JA. A rare toxic effect of local anaesthesia with lignocaine: a case report. Br J Anaesth 1958 30 : 377 9.
7. Sadove MS, Wyant GM, Gittelson LA, Kretchmer HE. Classification and management of reactions to local anesthetic agents. JAMA 1951 148 : 17 22.
8. Selden R, Sasahara AA. Central nervous system toxicity induced by lidocaine. Report of a case in a patient with liver disease. JAMA 1967 202 : 908 9.
9. Scott DB. Toxic effects of local anaesthetic agents on the central nervous system. Br J Anaesth 1986 58 : 732 5.
10. Davison R, Parker M, Atkinson AJ Jr. Excessive serum lidocaine levels during maintenance infusions: mechanisms and prevention. Am Heart J 1982 104 : 203 8.
11. Matharu MS, Cohen AS, Goadsby PJ. SUNCT syndrome responsive to intravenous lidocaine. Cephalalgia 2004 24 : 985 92.
12. Hosmer DW, Lemeshow S. Applied logistic regression, 2nd edn. New York : John Wiley & Sons 2000.
13. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders (second edition). Cephalalgia 2004 24 (Suppl. 1 1 160.
14. De Clive-Lowe SG, Gray PW, North J. Succinyldicholine and lignocaine by continuous intravenous drip; report of 1000 administrations. Anaesthesia 1954 9 : 96 104.
15. De Clive-Lowe SG, Desmond J, North J. Intravenous lignocaine anaesthesia. Anaesthesia 1958 13 : 138 46.
16. Bartlett EE, Hutserani O. Xylocaine for the relief of postoperative pain. Anesth Analg 1961 40 : 296 304.
17. Foldes FF, Molloy R, McNall PG, Koukal LR. Comparison of toxicity of intravenously given local anesthetic agents in man. JAMA 1960 172 : 1493 8.
18. Scott DB. Evaluation of the toxicity of local anaesthetic agents in man. Br J Anaesth 1975 47 : 56 61.
19. Rowlingson JC, DiFazio CA, Foster J, Carron H. Lidocaine as an analgesic for experimental pain. Anesthesiology 1980 52 : 20 2.
20. Korbon GA, Rowlingson JC, DiFazio CA. Sensitivity to pain predicts CNS sensitivity to lidocaine. Anesthesiology 1984 61 : 767 9.
21. Hayes JG, Ettinger E, Wanat FE, Killip T. Evaluation of lidocaine in the treatment of ventricular arrhythmia. Circulation 1967 36 (Suppl. 2 137.
22. Grossman JI, Lubow LA, Frieden J, Rubin IL. Lidocaine in cardiac arrhythmias. Circulation 1967 36 (Suppl. 2 126.
23. Anderson ST, Pitt A. Lignocaine in the management of ventricular arrhythmias. Med J Aust 1969 1 : 208 11.
24. Hilleman DE, Mohiuddin SM, Mooss AN, Hunter CB, Destache CJ, Sketch MH Sr. Comparative pharmacodynamics of intravenous lidocaine in patients with acute and chronic ventricular arrhythmias. Ann Pharmacother 1992 26 : 763 7.
25. Morganroth J, Panidis IP, Harley S, Johnson J, Smith E, MacVaugh H. Efficacy and safety of intravenous tocainide compared with intravenous lidocaine for acute ventricular arrhythmias immediately after cardiac surgery. Am J Cardiol 1984 54 : 1253 8.
26. Manolis AS, Smith E, Payne D, Rastegar H, Cleveland R, Estes NA 3rd. Randomized double-blind study of intravenous tocainide versus lidocaine for suppression of ventricular arrhythmias after cardiac surgery. Clin Cardiol 1990 13 : 177 81.
27. Grossman JI, Lubow LA, Frieden J, Rubin IL. Lidocaine in cardiac arrhythmias. Arch Intern Med 1968 121 : 396 401.
28. Gianelly R, von der Groeben JO, Spivack AP, Harrison DC. Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. N Engl J Med 1967 277 : 1215 19.
29. Jewitt DE, Kishon Y, Thomas M. Lignocaine in the management of arrhythmias after acute myocardial infarction. Lancet 1968 1 : 266 70.
30. Chopra MP, Portal RW, Aber CP. Lignocaine therapy after acute myocardial infarction. BMJ 1969 1 : 213 16.
31. Pfeifer HJ, Greenblatt DJ, Koch-Weser J. Clinical use and toxicity of intravenous lidocaine. A report from the Boston Collaborative Drug Surveillance Program. Am Heart J 1976 92 : 168 73.
32. Drayer DE, Lorenzo B, Werns S, Reidenberg MM. Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages. Clin Pharmacol Ther 1983 34 : 14 22.
33. Shih RD, Hollander JE, Burstein JL, Nelson LS, Hoffman RS, Quick AM. Clinical safety of lidocaine in patients with cocaine-associated myocardial infarction. Ann Emerg Med 1995 26 : 702 6.
34. Lown B, Vassaux C. Lidocaine in acute myocardial infarction. Am Heart J 1968 76 : 586 7.
35. Flensted-Jensen E, Sandoe E. Lidocaine as an antiarrhythmic. Experience in 68 patients. Acta Med Scand 1969 185 : 297 302.
36. Mogensen L. Ventricular tachyarrhythmias and lignocaine prophylaxis in acute myocardial infarction. A clinical and therapeutic study. Acta Med Scand 1970 513 (Suppl. 1 80.
37. Wyman MG, Hammersmith L. Comprehensive treatment plan for the prevention of primary ventricular fibrillation in acute myocardial infarction. Am J Cardiol 1974 33 : 661 7.
38. Wyman MG, Lalka D, Hammersmith L, Cannom DS, Goldreyer BN. Multiple bolus technique for lidocaine administration during the first hours of an acute myocardial infarction. Am J Cardiol 1978 41 : 313 17.
39. Buckman K, Claiborne K, de Guzman M, Walberg CB, Haywood LJ. Lidocaine efficacy and toxicity assessed by a new, rapid method. Clin Pharmacol Ther 1980 28 : 177 81.
40. Stargel WW, Shand DG, Routledge PA, Barchowsky A, Wagner GS. Clinical comparison of rapid infusion and multiple injection methods for lidocaine loading. Am Heart J 1981 102 : 872 6.
41. Dunn HM, McComb JM, Kinney CD, Campbell NP, Shanks RG, MacKenzie G et al. Prophylactic lidocaine in the early phase of suspected myocardial infarction. Am Heart J 1985 110 : 353 62.
42. Rademaker AW, Kellen J, Tam YK, Wyse DG. Character of adverse effects of prophylactic lidocaine in the coronary care unit. Clin Pharmacol Ther 1986 40 : 71 80.
43. Berntsen RF, Rasmussen K. Lidocaine to prevent ventricular fibrillation in the prehospital phase of suspected acute myocardial infarction: the North-Norwegian Lidocaine Intervention Trial. Am Heart J 1992 124 : 1478 83.
44. Jakobsen CJ, Ahlburg P, Holdgard HO, Olsen KH, Thomsen A. Comparison of intravenous and topical lidocaine as a suppressant of coughing after bronchoscopy during general anesthesia. Acta Anaesthesiol Scand 1991 35 : 238 41.
45. Lemmen LJ, Klassen M, Duiser B. Intravenous lidocaine in the treatment of convulsions. JAMA 1978 239 : 2025.
46. Pascual J, Sedano MJ, Polo JM, Berciano J. Intravenous lidocaine for status epilepticus. Epilepsia 1988 29 : 584 9.
47. Pascual J, Ciudad J, Berciano J. Role of lidocaine (lignocaine) in managing status epilepticus. J Neurol Neurosurg Psychiatry 1992 55 : 49 51.
48. Boas RA, Covino BG, Shahnarian A. Analgesic responses to i.v. lignocaine. Br J Anaesth 1982 54 : 501 5.
49. Cassuto J, Wallin G, Hogstrom S, Faxen A, Rimback G. Inhibition of postoperative pain by continuous low-dose intravenous infusion of lidocaine. Anesth Analg 1985 64 : 971 4.
50. Petersen P, Kastrup J, Zeeberg I, Boysen G. Chronic pain treatment with intravenous lidocaine. Neurol Res 1986 8 : 189 90.
51. Coe AJ, Dean J, McClone F, Leijon G, Bowsher D. On 'The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy' by Bach et al. in Pain, 40 (1990) 29-34. Pain 1991 46 : 232 3.
52. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991 41 : 1024 8.
53. Marchettini P, Lacerenza M, Marangoni C, Pellegata G, Sotgiu ML, Smirne S. Lidocaine test in neuralgia. Pain 1992 48 : 377 82.
54. Edmondson EA, Simpson RK Jr., Stubler DK, Beric A. Systemic lidocaine therapy for poststroke pain. South Med J 1993 86 : 1093 6.
55. Wallace MS, Dyck JB, Rossi SS, Yaksh TL. Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain 1996 66 : 69 77.
56. Galer BS, Harle J, Rowbotham MC. Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study. J Pain Symptom Manage 1996 12 : 161 7.
57. Ferrante FM, Paggioli J, Cherukuri S, Arthur GR. The analgesic response to intravenous lidocaine in the treatment of neuropathic pain. Anesth Analg 1996 82 : 91 7.
58. Maciewicz R, Borsook S, Strassman A. Intravenous lidocaine relieves acute vascular headache. Headache 1988 28 : 309.
59. Bell R, Montoya D, Shuaib A, Lee MA. A comparative trial of three agents in the treatment of acute migraine headache. Ann Emerg Med 1990 19 : 1079 82.
60. Reutens DC, Fatovich DM, Stewart-Wynne EG, Prentice DA. Is intravenous lignocaine clinically effective in acute migraine? Cephalalgia 1991 11 : 245 7.
61. Hand PJ, Stark RJ. Intravenous lignocaine infusions for severe chronic daily headache. Med J Aust 2000 172 : 157 9.
62. Williams DR, Stark RJ. Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia 2003 23 : 963 71.
63. Maciewicz R, Chung RY, Strassman A, Hochberg F, Moskowitz M. Relief of vascular headache with intravenous lidocaine: clinical observations and a proposed mechanism. Clin J Pain 1988 4 : 11 16.
64. Bennett ED. A personal account of lignocaine overdosage. Br J Anaesth 1957 29 : 81 3.
65. Bedynek JL Jr., Weinstein KN, Kah RE, Minton PR. Ventricular tachycardia. Control by intermittent, intravenous administration of lidocaine hydrochloride. JAMA 1966 198 : 553 5.
66. Crampton RS, Oriscello RG. Petit and grand mal convulsions during lidocaine hydrochloride treatment of ventricular tachycardia. JAMA 1968 204 : 201 4.
67. Ilyas M, Owens D, Kvasnicka G. Delirium induced by a combination of anti-arrhythmic drugs. Lancet 1969 2 : 1368 9.
68. Paloheimo JA. Prolonged continuous intravenous lignocaine in myocardial infarction. Lancet 1969 1 : 734 5.
69. Iwane T, Maruyama M, Matsuki M, Ito Y, Shimoji K. Management of intractable pain in adiposis dolorosa with intravenous administration of lidocaine. Anesth Analg 1976 55 : 257 9.
70. Graham CF, Turner WM, Jones JK. Lidocaine-propranolol interactions. N Engl J Med 1981 304 : 1301.
71. Fruncillo RJ, Gibbons W, Bowman SM. CNS toxicity after ingestion of topical lidocaine. N Engl J Med 1982 306 : 426 7.
72. Turner WM. Lidocaine and psychotic reactions. Ann Intern Med 1982 97 : 149 50.
73. Schneck DW. Therapeutic rounds at the Milton S. Hershey Medical Center. Clin Ther 1983 5 : 445 6.
74. Basile Filho A, Passos HV, Aldrighi JR, Maciel Junior JA. Acute psychotic reactions and speech disorders induced by the rapid intravenous injection of lidocaine. Rev Paul Med 1986 104 : 229.
75. Saravay SM, Marke J, Steinberg MD, Rabiner CJ Doom anxiety' and delirium in lidocaine toxicity. Am J Psychiatry 1987 144 : 159 63.
76. Bishop D, Johnstone RE. Lidocaine toxicity treated with low-dose propofol. Anesthesiology 1993 78 : 788 9.
77. Chiang YY, Tseng KF, Lih YW, Tsai TC, Liu CT, Leung HK. Lidocaine-induced CNS toxicity - a case report. Acta Anaesthesiol Sin 1996 34 : 243 6.
78. Humbert P, Girardin P, Aubin F. Fear of dying after intra-keloid injection of triamcinolone acetonide and lidocaine: Hoigne's syndrome. Ann Dermatol Venereol 2001 128 : 762.
79. Gordh T. Xylocain - a new local analgesic. Anaesthesia 1949 4 : 4 9.
80. Alfano SN, Leicht MJ, Skiendzielewski JJ. Lidocaine toxicity following subcutaneous administration. Ann Emerg Med 1984 13 : 465 7.
81. Mack RB. Please pass me the onions and the socks - lidocaine toxicity. N C Med J 1983 44 : 485 6.
82. Hashimoto K, Sakura S, Bollen AW, Ciriales R, Drasner K. Comparative toxicity of glucose and lidocaine administered intrathecally in the rat. Reg Anesth Pain Med 1998 23 : 444 50.
83. Freedman JM, Li D, Drasdner K, Jaskela MC, Larsen B, Wi S. Transient neurologic symptoms after spinal anesthesia. An epidemiological study of 1863 patients. Anesthesia 1998 89 : 633 41.
84. Wagman IH, De Jong RH, Prince DA. Effects of lidocaine on spontaneous cortical and subcortical electrical activity. Production of seizure discharges. Arch Neurol 1968 18 : 277 90.
85. Mesulam MM. Lidocaine toxicity and the limbic system. Am J Psychiatry 1987 144 : 1623 4.
86. Araskiewicz A, Rybakowski JK. Hoigne's syndrome: a procaine-induced limbic kindling. Med Hypotheses 1994 42 : 261 4.